RHUMBLINE ADVISERS – Regeneron Pharmaceuticals, Inc. Transaction History
RHUMBLINE ADVISERS portfolio value:
$123.30M
portfolio value
RHUMBLINE ADVISERS quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +3.13% | 5.42K shares | 20.70M | $688.87 | 178.99K |
| Q2 2022 | share | Increase | +6.40% | 10.44K shares | -11.32M | $591.13 | 173.57K |
| Q1 2022 | share | Increase | +0.70% | 1.12K shares | 11.62M | $698.42 | 163.12K |
| Q4 2021 | share | Increase | +0.45% | 732 shares | 4.71M | $642.51 | 161.99K |
| Q3 2021 | share | Decrease | -0.32% | -525 shares | 7.22M | $605.18 | 161.26K |
| Q2 2021 | share | Decrease | -2.09% | -3.45K shares | 12.18M | $558.54 | 161.79K |
| Q1 2021 | share | Decrease | -4.96% | -8.62K shares | -5.81M | $473.14 | 165.25K |
| Q4 2020 | share | Decrease | -9.85% | -19.00K shares | -23.96M | $483.11 | 173.87K |
| Q3 2020 | share | Decrease | -1.54% | -3.01K shares | -14.20M | $559.78 | 192.87K |
| Q2 2020 | share | Increase | +33.76% | 49.44K shares | 50.66M | $623.65 | 195.89K |
| Q1 2020 | share | Increase | +0.26% | 387 shares | 16.66M | $488.29 | 146.44K |
| Q4 2019 | share | Increase | +3.24% | 4.58K shares | 15.59M | $375.48 | 146.06K |
| Q3 2019 | share | Increase | +4.72% | 6.37K shares | -3.04M | $277.4 | 141.48K |
| Q2 2019 | share | Increase | +1.72% | 2.28K shares | -12.25M | $313 | 135.10K |
| Q1 2019 | share | Decrease | -9.79% | -14.41K shares | -453K | $410.62 | 132.82K |
| Q4 2018 | share | Increase | +0.76% | 1.10K shares | -4.05M | $373.5 | 147.23K |
| Q3 2018 | share | Decrease | -0.91% | -1.33K shares | 8.16M | $404.04 | 146.13K |
| Q2 2018 | share | Increase | +2.86% | 4.09K shares | 1.50M | $344.99 | 147.46K |
| Q1 2018 | share | Increase | +0.10% | 148 shares | -4.47M | $344.36 | 143.37K |
| Q4 2017 | share | Increase | +5.87% | 7.93K shares | -6.64M | $375.96 | 143.22K |
| Q3 2017 | share | Increase | +1.52% | 2.03K shares | -4.95M | $447.12 | 135.28K |
| Q2 2017 | share | Increase | +1.62% | 2.12K shares | 14.63M | $491.14 | 133.25K |
| Q1 2017 | share | Increase | +2.20% | 2.82K shares | 3.71M | $387.51 | 131.13K |
| Q4 2016 | share | Increase | +1.73% | 2.17K shares | -3.60M | $367.09 | 128.30K |
| Q3 2016 | share | Increase | +2.60% | 3.2K shares | 7.77M | $402.02 | 126.12K |
| Q2 2016 | share | Increase | +3.75% | 4.43K shares | 221K | $349.23 | 122.92K |
| Q1 2016 | share | Increase | +3.82% | 4.35K shares | -19.25M | $360.44 | 118.49K |